Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 open-label L-arginine in HAM/TSP
jRCTs071180068Phase 1Completed
- Start
- Nov 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of arginine in HTLV-1-associated myelopathy (HAM). Primary endpoints: Time for walking 10 meters on Day 7 and Number of steps for walking 10 meters on Day 7. Started Nov 2016; status: completed.
02
Drugs
arginine
03
Conditions
HTLV-1-associated myelopathy (HAM)
Beyond the preview
Go deeper on jRCTs071180068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180068.